Citi Reiterates Buy Rating on DexCom (DXCM), 'Favorable Court Ruling'
Tweet Send to a Friend
Citi analyst Joanna Wuensch reiterated a Buy rating and $148.00 price target on DexCom (NASDAQ: DXCM).The analyst said: "DXCM is ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
